drugset / Trial / NCT06834087

Laser Treatment with Methylene Blue Vs. Nanoparticle-Assisted Photodynamic Therapy for Gingival Pigmentation: a Randomized Clinical Trial

NCT06834087

Enrolling by invitation 45 enrolled Roaa Hadi Hussein Jasem
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled clinical trial aims to compare the effectiveness of methylene blue and methylene blue nanoparticles as adjuncts to photodynamic therapy in laser treatment of physiological gingival pigmentation. The study evaluates pigmentation reduction, recurrence rates, healing time, and patient satisfaction. Conducted at Kafrelsheikh University, it includes three patient groups: laser-only treatment, conventional methylene blue-assisted PDT with laser, and methylene blue nanoparticles-assisted PDT with laser. The findings will contribute to advancements in aesthetic dentistry and laser-assisted depigmentation techniques.

Timeline

Start
2025-03-15
Primary completion
2025-09-14
Completion
2025-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylene Blue Diagnostic / imaging agent 0.1 % Topical
Comparator Methylene Blue Nanoparticles Unknown 0.1 % Topical